Show simple item record

dc.contributor.authorHomei, Aya
dc.contributor.authorWorboys, Michael
dc.date.accessioned2021-02-10T12:58:18Z
dc.date.issued2013
dc.date.submitted2020-03-18 13:36:15
dc.date.submitted2020-04-01T12:40:33Z
dc.date.submitted2014-05-07 23:55
dc.date.submitted2020-03-18 13:36:15
dc.date.submitted2020-04-01T12:40:33Z
dc.identifier1000006
dc.identifierOCN: 1076726909
dc.identifierhttp://library.oapen.org/handle/20.500.12657/29948
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/29579
dc.description.abstractIn this book, we discuss the changing medical and public profile of fungal infections in the period 1850–2000. We consider four sets of diseases: ringworm and athlete’s foot (dermatophytosis); thrush or candidiasis (infection with Candida albicans); endemic, geographically specific infections in North America (coccidioidomycosis, blastomycosis and histoplasmosis) and mycotoxins; and aspergillosis (infection with Aspergillus fumigatus). We discuss each disease in relation to developing medical knowledge and practices, and to social changes associated with ‘modernity’. Thus, mass schooling provided ideal conditions for the spread of ringworm of the scalp in children, and the rise of college sports and improvement of personal hygiene led to the spread of athlete’s foot. Antibiotics seemed to open the body to more serious Candida infections, as did new methods to treat cancers and the development of transplantation. Regional fungal infections in North America came to the fore due to the economic development of certain regions, where population movement brought in non-immune groups who were vulnerable to endemic mycoses. Fungal toxins or mycotoxins were discovered as by-products of modern food storage and distribution technologies. Lastly, the rapid development and deployment of new medical technologies, such as intensive care and immunosuppression in the last quarter of the twentieth century, increased the incidence of aspergillosis and other systemic mycoses.
dc.languageEnglish
dc.relation.ispartofseriesScience, Technology and Medicine in Modern History
dc.rightsopen access
dc.subject.classificationbic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJC Diseases & disorders
dc.subject.othercandidiasis
dc.subject.othermycotoxins
dc.subject.otheraspergillosis
dc.subject.otherfungal infections
dc.subject.otherdermatophytosis
dc.titleChapter Acknowledgements
dc.title.alternativeMycoses and Modernity
dc.typechapter
oapen.relation.isPublishedBy9fa3421d-f917-4153-b9ab-fc337c396b5a
oapen.relation.isPartOfBookb9afa9e9-9741-4e3d-91bb-bf1ef61ffc57
oapen.relation.isFundedByd859fbd3-d884-4090-a0ec-baf821c9abfd
oapen.relation.isFundedByf6fcd900-36e2-4bc9-939e-ad820802e21f
oapen.collectionWellcome
oapen.imprintPalgrave Macmillan
oapen.pages225
oapen.place.publicationBasingstoke
oapen.grant.number074971
dc.relationisFundedByd859fbd3-d884-4090-a0ec-baf821c9abfd
dc.chapternumber1


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

open access
Except where otherwise noted, this item's license is described as open access